The program will include sessions on:
- Small molecule modulation of stem cell differentiation
- Development of disease models using gene editing of hESCs and patient-derived iPSCs
- Instrumental methods for phenotypic chemical library screening
- 3D cell culture models and organoids in disease modelling
- Future uses of stem cell technology in the pharmaceutical industry
Full program will be available from early 2018.